An announcement from NewAmsterdam Pharma Company (NAMS) is now available.
NewAmsterdam Pharma Company N.V. has announced Juliette Audet’s new role as Chief Business Officer, effective April 1, 2024. Coinciding with this transition, Audet stepped down from the company’s board of directors, a move made without any internal disagreements. This leadership change has been publicly shared, but the specifics are not considered legally filed information for regulatory purposes.
See more data about NAMS stock on TipRanks’ Stock Analysis page.
